The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Oxytocin Infusion Reduces Repetitive Behaviors in Adults with Autistic and Asperger's Disorders
Abstract
Autism is a neurodevelopmental disorder characterized by dysfunction in three core behavioral domains: repetitive behaviors, social deficits, and language abnormalities. There is evidence that abnormalities exist in peptide systems, particularly the oxytocin system, in autism spectrum patients. Furthermore, oxytocin and the closely related peptide vasopressin are known to play a role in social and repetitive behaviors. This study examined the impact of oxytocin on repetitive behaviors in 15 adults with autism or Asperger's disorder via randomized double-blind oxytocin and placebo challenges. The primary outcome measure was an instrument rating six repetitive behaviors: need to know, repeating, ordering, need to tell/ask, self-injury, and touching. Patients with autism spectrum disorders showed a significant reduction in repetitive behaviors following oxytocin infusion in comparison to placebo infusion. Repetitive behavior in autism spectrum disorders may be related to abnormalities in the oxytocin system, and may be partially ameliorated by synthetic oxytocin infusion.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Improvements in repetitive behaviors in adults with autism following oxytocin infusion have been demonstrated [169] as well as positive effects on social behaviors and cognition [170].”
From Consensus Paper: Pathological Role of the Cerebellum in Autism (2012) · cites this paper as [169]
In the citing paper
“The neuromodulator oxytocin (OT) has been shown to improve social deficits in both ASD and other disorders accompanied by social deficits (Guastella et al., 2010, 2010; Hollander et al., 2002, 2007; Yatawara et al., 2015; Young and Barrett, 2015).”
From Oxytocin enhances gaze-following responses to videos of natural social behavior in adult male rhesus monkeys (2016) · cites this paper as Hollander et al., 2002
In the citing paper
“reduce repetitive behaviors (Hollander et al., 2003)”
From Effects of intranasal oxytocin on social anxiety in males with fragile X syndrome (2012) · cites this paper as Hollander et al., 2003
In the citing paper
“This study demonstrated that administration of OT led to a decrease in a core ASD symptom, RRB.”
From Oxytocin and vasopressin systems in genetic syndromes and neurodevelopmental disorders (2014) · cites this paper as Hollander et al., 2003
In the citing paper
“Overall, these observed effects on repetitive behaviors are in line with previous trials with adult men with ASD showing beneficial effects of OT on repetitive behaviors after 4 h of intravenous OT administration [4] and after 6 weeks of daily administrations [8, 10].”
From Behavioral effects of multiple-dose oxytocin treatment in autism: a randomized, placebo-controlled trial with long-term follow-up (2020) · cites this paper as [4]
In the citing paper
“In this view, it appears that beneficial effects of OT treatment on repetitive behaviors were mostly demonstrated in studies that adopted assessments based on self-reports (current study, [4, 8]), whereas no beneficial effects were evident in studies adopting informant-based reports of repetitive behavior [9–14].”
From Behavioral effects of multiple-dose oxytocin treatment in autism: a randomized, placebo-controlled trial with long-term follow-up (2020) · cites this paper as [4]
In the citing paper
“There is both animal (Popik et al., 1992) and human (Hollander et al., 2007(Hollander et al., , 2003) ) research to suggest systemic OT can influence social behavior and cognition”
From Low dose intranasal oxytocin delivered with Breath Powered device dampens amygdala response to emotional stimuli: A peripheral effect-controlled within-subjects randomized dose-response fMRI trial (2016) · cites this paper as Hollander et al., 2003
In the citing paper
“oxytocin , relative to placebo, reduces repetitive stereotypic behaviors [172]”
From Social “wanting” dysfunction in autism: neurobiological underpinnings and treatment implications (2012) · cites this paper as [172]
Citations
Cites
Lord, C., Rutter, M., & Le Couteur, A. (1994) · Journal of Autism and Developmental Disorders · doi:10.1007/bf02172145 · Cited by 9,065
The neurobiology of attachment
Insel, T. R., & Young, L. J. (2001) · Nature Reviews Neuroscience · doi:10.1038/35053579 · Cited by 1,173
Social amnesia in mice lacking the oxytocin gene
Ferguson, J. N., Young, L. J., Hearn, E. F., Matzuk, M. M., Insel, T. R., & Winslow, J. T. (2000) · Nature Genetics · doi:10.1038/77040 · Cited by 1,130
A role for central vasopressin in pair bonding in monogamous prairie voles
Winslow, J. T., Hastings, N., Carter, C. S., Harbaugh, C. R., & Insel, T. R. (1993) · Nature · doi:10.1038/365545a0 · Cited by 948 · cited 1×
“For males, vasopressin has been shown to evoke partner preference and aggression after mating (Winslow et al, 1993).”
BackgroundOxytocin is required for nursing but is not essential for parturition or reproductive behavior.
Nishimori, K., Young, L. J., Guo, Q., Wang, Z., Insel, T. R., & Matzuk, M. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11699 · Cited by 734
Plasma oxytocin levels in autistic children
Modahl, C., Green, L. A., Fein, D., Morris, M., Waterhouse, L., Feinstein, C., & Levin, H. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00439-3 · Cited by 728
Insel, T. R., & Hulihan, T. J. (1995) · Behavioral Neuroscience · doi:10.1037/0735-7044.109.4.782 · Cited by 528
Oxytocin and autistic disorder: alterations in peptide forms
Green, L., Fein, D., Modahl, C., Feinstein, C., Waterhouse, L., & Morris, M. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01139-8 · Cited by 404
Behavioral effects of intraventricularly administered vasopressin and vasopressin fragments
de Wied, D. (1976) · Life Sciences · doi:10.1016/0024-3205(76)90165-x · Cited by 359
Central Nervous System Effects of the Neurohypophyseal Hormones and Related Peptides
de Wied, D., Diamant, M., & Fodor, M. (1993) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1993.1009 · Cited by 327
Cited by
Sorted by citations
Items 501–600 of 704
Microfluidics-Assisted Formulation of Polymeric Oxytocin Nanoparticles for Targeted Brain Delivery
Adediran, E. O., Vijayanand, S., Kale, A., Gulani, M. A., Wong, J. C., Escayg, A., Murnane, K. S., & D’Souza, M. J. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17040452 · Cited by 6
CRISPR/Cas9‐induced nos2b mutant zebrafish display behavioral abnormalities
Gao, L., Penglee, R., Huang, Y., Yi, X., Wang, X., Liu, L., Gong, X., & Bao, B. (2020) · Genes Brain & Behavior · doi:10.1111/gbb.12716 · Cited by 6
Ben‐Sasson, A., & Stephenson, K. G. (2021) · Autism and child psychopathology series · doi:10.1007/978-3-030-66445-9_11 · Cited by 6
Walker, M. A. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.8.949 · Cited by 6
Husarova, V. M., Lakatošová, S., Pivovarciova, A., Bakoš, J., Durdiaková, J., Kubranská, A., & Ostatníková, D. (2013) · Open Journal of Psychiatry · doi:10.4236/ojpsych.2013.34043 · Cited by 6
Type, Topography, and Sequelae of Neuropathological Changes Shaping Clinical Phenotype of Autism
Węgiel, J., Wısnıewskı, T., Chauhan, A., Chauhan, V. P. S., Kuchna, I., Nowicki, K., Imaki, H., Wegiel, J., Ma, S., Wierzba‐Bobrowicz, T., et al. (2009) · CRC Press eBooks · doi:10.1201/9781420068870-c1 · Cited by 6
Impact of Infant Feeding Methods on the Development of Autism Spectrum Disorder
Shafai, T., Mustafa, M., Mulari, J., & Curtis, A. (2017) · InTech eBooks · doi:10.5772/67624 · Cited by 6
Suggested Improvements to the Overt Aggression Scale-Modified
Mattes, J. A. (2010) · Journal of Neuropsychiatry · doi:10.1176/jnp.2010.22.1.123.e1 · Cited by 6
Combined Medication and Dialectical Behavior Therapy for Borderline Personality Disorder
Schulz, S. C., & Rafferty, M. P. (2008) · Social Work in Mental Health · doi:10.1300/j200v06n01_11 · Cited by 6
Recent approaches to pharmacotherapy of personality disorders
Bellino, S., Rinaldi, C., Bozzatello, P., & Bogetto, F. (2011) · Neuropsychiatry · doi:10.2217/npy.11.17 · Cited by 6
Azimigarosi, S., Arjmandnia, A., Ezhei, A. M., & Asgari, M. (2020) · Quarterly Journal of Child Mental Health · doi:10.29252/jcmh.6.4.5 · Cited by 6
Johnson, C. P., & Myers, S. M. (2008) · Elsevier eBooks · doi:10.1016/b978-0-323-04025-9.50018-0 · Cited by 6
Karbasi, A., Isfahani, S. S., Maracy, M. R., & Sabzghabaee, A. M. (2023) · Middle East Current Psychiatry · doi:10.1186/s43045-023-00300-w · Cited by 6
Vanakara, P., Dafopoulos, K. C., Papastergiopoulou, L., Kallitsaris, A., Papageorgiou, I., & Messinis, I. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02818.x · Cited by 6
Modeling Features of Autism in Animals
Patterson, P. H. (2006) · CRC Press eBooks · doi:10.1201/9781420004205-18 · Cited by 6
Preclinical Animal Models of Autistic Spectrum Disorders (ASD)
Bartz, J. A., Young, L. J., Hollander, E., Buxbaum, J. D., & Ring, R. H. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373861-5.00011-4 · Cited by 6
Self-citationZhang, Y., Zhang, X., & Huang, L. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1477076 · Cited by 5
The Male Prevalence in Autism Spectrum Disorders: Hypotheses on its Neurobiological Basis
Keller, F., & Ruta, L. (2010) · Springer eBooks · doi:10.1007/978-1-4419-1272-5_2 · Cited by 5
Portnova, G. V., Proskurnina, E. V., Skorokhodov, I. V., Sokolova, S. V., Semirechenko, A., & Алексеевич, В. А. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512322 · Cited by 5
Akingbala, F., Dhanani, N., & Brown, E. S. (2006) · Journal of Dual Diagnosis · doi:10.1300/j374v02n03_07 · Cited by 5
Modeling oxytocin induced neurorobotic trust and intent recognition in human-robot interaction
Anumandla, S. R., Bray, L. C. J., Thibeault, C. M., Hoang, R. V., Dascalu, S. M., Harris, F. C., & Goodman, P. H. (2011) · International Joint Conference on Neural Networks (IJCNN) · doi:10.1109/ijcnn.2011.6033647 · Cited by 5
The Role of Oxytocin in Neuropsychiatric Disorders: Concepts and Mechanisms
Levin, R., Edelman, S., Shalev, I., Ebstein, R. P., & Heresco‐Levy, U. (2010) · Springer eBooks · doi:10.1007/978-90-481-8553-5_20 · Cited by 5
Oksitosin ve Psikiyatrik Bozukluklar
Say, G. N., & Müjdeci, M. (2016) · Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry · doi:10.18863/pgy.17749 · Cited by 5
Yue, X., Lu, L., Liu, H., & Xue, H. (2018) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2018.11.045 · Cited by 5
Sinzig, J. (2015) · Monatsschrift Kinderheilkunde · doi:10.1007/s00112-014-3242-2 · Cited by 5
Hochfunktionaler Autismus des Erwachsenenalters
Lehnhardt, F., & Vogeley, K. T. (2008) · Nervenheilkunde · doi:10.1055/s-0038-1627111 · Cited by 5
Volitional disorders: A proposal for DSM-V
Fontenelle, L. F., Mendlowicz, M. V., & Versiani, M. (2008) · The World Journal of Biological Psychiatry · doi:10.1080/15622970701858771 · Cited by 5
Bilke, O., & von Brisinski, I. S. (2009) · Monatsschrift Kinderheilkunde · doi:10.1007/s00112-008-1930-5 · Cited by 5
Wolfe, M., Wisniewska, H., Tariga, H., Ibanez, G., Collins, J. C., Wiśniewski, K., Qi, S., Srinivasan, K., Hargrove, D. M., & Lindstrom, B. (2018) · Neuropeptides · doi:10.1016/j.npep.2018.05.007 · Cited by 5
Hochfunktionaler Autismus im Erwachsenenalter
Vogeley, K. T., & Remschmidt, H. (2009) · Elsevier eBooks · doi:10.1016/b978-3-437-24900-6.50023-x · Cited by 5
Cholesterol allosteric modulation of the oxytocin receptor
Marlow, B., Vogel, A., Kuenze, G., Pankonin, M., Reinhardt, F., Stadler, P. F., Hildebrand, P. W., & Meiler, J. (2025) · Biophysical Journal · doi:10.1016/j.bpj.2025.04.023 · Cited by 4
Samoilova, I. G., Матвеева, М. В., & Galyukova, D. E. (2024) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202412401155 · Cited by 4
Angelopoulou, M., Siaperas, P., Livadas, S., Karantana, E., Papadimitriou, D. T., & Angelopoulos, N. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.09.009 · Cited by 4
Denda, M. (2016) · Springer eBooks · doi:10.1007/978-3-319-43157-4_19 · Cited by 4
Filippo, G. D., & Perri, R. L. (2024) · Frontiers in Psychology · doi:10.3389/fpsyg.2024.1326170 · Cited by 4
Grandmotherhood is associated with reduced OXTR DNA methylation
Rilling, J. K., Lee, M., Zhou, C., Gonzalez, A., & Lindo, J. (2024) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2024.107122 · Cited by 4
A Candidate Circuit Approach to Investigating Autism
Page, D. T. (2011) · The Anatomical Record · doi:10.1002/ar.21473 · Cited by 4
Levallois, S., Béraud, J., & Jalenques, I. (2007) · Annales Médico-psychologiques revue psychiatrique · doi:10.1016/j.amp.2006.12.002 · Cited by 4
Yui, K., & Koshiba, M. (2012) · Journal of Addiction Research & Therapy · doi:10.4172/2155-6105.s4-006 · Cited by 4
Efficacy of Yoga as an Add-On Treatment of Schizophrenia
Chawla, R. (2018) · Indian Journal of Health and Wellbeing · Cited by 4
Bhagvad Gita, gut microbiota, and mental health
Sheth, H. C. (2021) · Yoga Mimamsa · doi:10.4103/ym.ym_24_20 · Cited by 4
McGregor, I. S., & Bowen, M. T. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139017855.018 · Cited by 4
Psychotropic Treatment of Autism
Pallanti, S., Bencini, L., Cantisani, A., & Hollander, E. (2015) · Key issues in mental health (Online)/Key issues in mental health (Print) · doi:10.1159/000363614 · Cited by 4
Self-citationNorholt, H. (2021) · Frontiers in Psychology · doi:10.3389/fpsyg.2020.590051 · Cited by 4
The Current Status of Drug Discovery for the Oxytocin Receptor
Nashar, P. E., Whitfield, A. A., Mikušek, J., & Reekie, T. A. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1759-5_10 · Cited by 4
Anpassungsstörung, akute und posttraumatische Belastungsstörung
Kapfhammer, H. (2011) · Springer eBooks · doi:10.1007/978-3-642-03637-8_59 · Cited by 4
Oxytocin and opioid antagonists: A dual approach to improving social behavior
Monte, O. D., Gangopadhyay, P., Putnam, P. T., & Chang, S. W. C. (2025) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.15376 · Cited by 3
Neural Targets in the Study and Treatment of Social Cognition in Autism Spectrum Disorder
Vahabzadeh, A. B. N., Landino, S. M., Finger, B. C., Carlezon, W. A., & McDougle, C. J. (2015) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-16522-6_11 · Cited by 3
L’autisme à l’âge adulte : bilan diagnostique et aspects thérapeutiques
Murad, A., Fritsch, A., Bizet, É., & Schaal, C. (2014) · Annales Médico-psychologiques revue psychiatrique · doi:10.1016/j.amp.2014.07.011 · Cited by 3
Can Oxytocin Improve Core Brain and Behavioral Features of Autism Spectrum Disorders in Children?
Gordon, I. (2013) · Research and perspectives in neurosciences · doi:10.1007/978-3-319-02904-7_11 · Cited by 3
DOĞAL VE SENTETİK OKSİTOSİNİN DOĞUM SONU EMZİRME BAŞARISI VE BAĞLANMAYA ETKİSİ
ÖZÇALKAP, N., Uçar, T., & Taştan, S. (2024) · Samsun Sağlık Bilimleri Dergisi · doi:10.47115/jshs.1339223 · Cited by 3
A Practitioner’s Guide to Prescribing Valproate for Adults with Intellectual Disabilities
de León, J. (2012) · Springer eBooks · doi:10.1007/978-1-4614-2012-5_21 · Cited by 3
Genes Related to Autistic Traits and Empathy
Chakrabarti, B., & Baron‐Cohen, S. (2011) · Wiley eBooks · doi:10.1002/9781118101803.ch1 · Cited by 3
Pavlovic, Z. M. (2008) · Journal of Neuropsychiatry · doi:10.1176/jnp.2008.20.1.121 · Cited by 3
The Role of Oxytocin in Autism Spectrum Disorders
Canitano, R., & Scandurra, V. (2012) · Current Psychopharmacologye · doi:10.2174/2211556011201020178 · Cited by 3
From bedside to bench and back: Translating ASD models
Drozd, H. P., Karathanasis, S. F., Molosh, A. I., Lukkes, J. L., Clapp, D. W., & Shekhar, A. (2018) · Progress in brain research · doi:10.1016/bs.pbr.2018.10.003 · Cited by 3
Perspectivas neurobiológicas para explicar el autismo: una revisión sistemática de literatura
Sosa, M., Alessandroni, N., & Piro, M. C. (2017) · Revista de Psicología · doi:10.24215/2422572xe60-96 · Cited by 3
Evidence for intranasal oxytocin delivery to the brain: recent advances and future perspectivesPreprint
Quintana, D. S., Smerud, K. T., Andreassen, O. A., & Djupesland, P. G. (2018) · OSF Preprints (OSF Preprints) · doi:10.31219/osf.io/fnhx5 · Cited by 3
Kang, H., Glaser, B. D., Sartorius, A. M., Audunsdottir, K., Nærland, T., Andreassen, O. A., Westlye, L. T., & Quintana, D. S. (2022) · OSF Preprints (OSF Preprints) · doi:10.31219/osf.io/8fzdy · Cited by 3
Munesue, T., 芦村, 和., Nakatani, H., Kikuchi, M., Yokoyama, S., Oi, M., Higashida, H., & Minabe, Y. (2012) · InTech eBooks · doi:10.5772/48798 · Cited by 2
A narrative exploration of oxytocin and anxiety in autism spectrum disorder
Koche, S., Gajghate, M., Vinchurney, M. D., Kale, M. B., Taksande, B. G., Umekar, M. J., & Trivedi, R. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149991 · Cited by 2
Otkiran, G., Erdoğan, M. A., Uyanıkgil, Y., & Erbaş, O. (2026) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-025-10275-6 · Cited by 2
Neuropeptidergic systems in psychiatric disorders
Hodzic, S., & Riedemann, T. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1654292 · Cited by 2
Collongues, N., Cretin, B., Seze, J. D., & Blanc, F. (2010) · Revue Neurologique · doi:10.1016/j.neurol.2010.03.023 · Cited by 2
Demartini, B., Nisticò, V., Bertino, V., Faggioli, R., Casiraghi, A., Mazza, D., Ferrucci, R., Priori, A., & Gambini, O. (2020) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001323 · Cited by 2
Social dysfunction in autism spectrum disorder: Tactility and oxytocin
Yujie, H., Rong, Z., Libinuer·aierken, K., Jingjing, L., Junqi, W., Haiping, P., & Jun, G. (2023) · Advances in Psychological Science · doi:10.3724/sp.j.1042.2023.00800 · Cited by 2
Tenne, Y., Kahalon, R., Daari, L., Preis, H., Eisner, M., Chen, R., Mor, P., Granovsky, S. G., Samueloff, A., & Benyamini, Y. (2023) · The Journal of Perinatal & Neonatal Nursing · doi:10.1097/jpn.0000000000000760 · Cited by 2
A multiverse meta-analysis of oxytocin administration studies
Kang, H., Deilhaug, E., Walle, K. M., Sartorius, A. M., & Quintana, D. S. (2025) · Biological Psychology · doi:10.1016/j.biopsycho.2025.109112 · Cited by 2
Yılmazer, E., Çınaroğlu, M., Köse, S. K., Ülker, S. V., & Tarlacı, S. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14196760 · Cited by 2
Walh, R. U. R. (2007) · PubMed · Cited by 2
The Perinatal Application of Oxytocin and Its Possible Influence on the Human Psyche
Plothe, C. (2009) · Cited by 2
Scientifically Unsupported Therapies in the Treatment of Young Children with Autism Disorders
(2007) · Psychiatric Annals · doi:10.3928/00485713-20070901-05 · Cited by 2
Brain Mechanisms Theoretically Underlying Extremes of Social Behaviors: The Best and the Worst
Choleris, E., Kavaliers, M., & Pfaff, D. W. (2008) · Springer eBooks · doi:10.1007/978-3-540-79288-8_2 · Cited by 2
Persistent Neurobehavioral Signs and Symptoms Following West Nile Fever
Hall, D. A., Tyler, K. L., Frey, K., Kozora, E., & Arciniegas, D. B. (2008) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.20.1.122 · Cited by 2
Central modulation of affective touch, pain, and emotion in humans
Ellingsen, D. (2014) · Cited by 2
Oxytocin but Not Testosterone Modulates Behavioral Patterns in Autism Spectrum Disorders
Lakatošová, S., Sheinberg, N., Pivovarciova, A., Husarova, V. M., Rozenfeld, I., Ostatníková, D., & Castejon, A. M. (2014) · Open Journal of Medical Psychology · doi:10.4236/ojmp.2014.31006 · Cited by 2
Walker, M. A. (2006) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.16.3.249 · Cited by 2
Evidence-Based Pharmacotherapy for Personality Disorders
Ripoll, L. H., Triebwasser, J., & Siever, L. J. (2013) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.11.2.225 · Cited by 2
Wang, Q. M., Luo, A., & Kong, X. (2014) · Cited by 2
The Biomaterial Relevance of Oxytocin in Some Zebrafish Studies
Plavan, G. I., Ciobica, A. S., Nicoară, M., & Timofte, D. V. (2015) · Key engineering materials · doi:10.4028/www.scientific.net/kem.660.289 · Cited by 2
Prenatal β2-Adrenergic Receptor Signaling and Autism:
Connors, S. L. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-489-0_7 · Cited by 2
Recent Clinical Research on Effect of Acupuncture for Autism Spectrum Disorder
Lee, J. N., Lee, S. H., & Lee, J. Y. (2015) · The Journal of Pediatrics of Korean Medicine · doi:10.7778/jpkm.2015.29.4.119 · Cited by 2
Potential use in cellular treatment of oxytocin
Sır, G. (2015) · Istanbul Bilim University Florence Nightingale Journal of Medicine · doi:10.5606/fng.btd.2015.030 · Cited by 2
Sano, Y., & Watanabe, N. (2016) · Clinical & Medical Biochemistry Open Access · doi:10.4172/2471-2663.1000113 · Cited by 2
Marinova, Z., Walitza, S., & Grünblatt, E. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1778-8 · Cited by 2
Green, J. J., Taylor, B. P., & Hollander, E. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139017855.024 · Cited by 2
Self-citationAnpassungsstörung, akute und posttraumatische Belastungsstörung
Kapfhammer, H. P. (2008) · Springer eBooks · doi:10.1007/978-3-540-33129-2_60 · Cited by 2
Higashida, H., Jin, D., Liu, H.-X., Lopatina, O. L., Yokoyama, S., Koizumi, K., Hashii, M., Islam, M. S., Hayashi, K., & Munesue, T. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-374285-8.00023-8 · Cited by 2
Harmon, K. M. (2006) · OhioLink ETD Center (Ohio Library and Information Network) · Cited by 2
Pharmakotherapie der Akuten und Posttraumatischen Belastungsstörung
Kapfhammer, H. (2005) · Psychiatrie und Psychotherapie · doi:10.1007/s11326-005-0005-7 · Cited by 2
Herpertz, S. C. (2008) · Springer eBooks · doi:10.1007/978-3-540-68748-1_50 · Cited by 2
Linked OXTR Variants Are Associated With Social Behavior Differences in Bonobos ( Pan paniscus )Preprint
Skiba, S. A., McCall, R., Byers, A., Waldron, S., Epping, A. J., & Taglialatela, J. P. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.12.22.573122 · Cited by 2
Самойлова, Ю. Г., Матвеева, М. В., & Galyukova, D. E. (2024) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-024-01633-7 · Cited by 1
Sabadini, G., Palacios-Muñoz, A., García, I. E., Romero‐Parra, J., Moraga, D., Soto, M., Vega-Muñoz, A., Contreras-Barraza, N., Salazar-Sepúlveda, G., Mella, J., et al. (2026) · Pharmaceuticals · doi:10.3390/ph19010102 · Cited by 1
Imprinting and psychiatric genetics: Beware the diagnostic phenotype
Goos, L. M. (2008) · Behavioral and Brain Sciences · doi:10.1017/s0140525x08004317 · Cited by 1
Biological Treatment of Asperger'sDisorder
Londino, D. L., Mattingly, D., & Janowsky, D. S. (2008) · Medical psychiatry · doi:10.3109/9780849383649.013 · Cited by 1
Berlin, H. A., & Hollander, E. (2008) · Medical psychiatry · doi:10.3109/9780849382666.017 · Cited by 1
Self-citationBiochemistry of autism: changes in serotonin, reelin and oxytocin
Mukaetova‐Ladinska, E. B., Westwood, J., & Perry, E. K. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511973918.009 · Cited by 1
Phase II and III drugs for the treatment of fragile X syndrome
Politte, L. C., & McDougle, C. J. (2012) · Expert Opinion on Orphan Drugs · doi:10.1080/21678707.2013.750240 · Cited by 1
Oxytocin, Oxytocin Receptor Genotypes and Social Adaptive Behavior
Nan, W. U., & Yanjie, S. (2013) · Advances in Psychological Science · doi:10.3724/sp.j.1042.2012.00863 · Cited by 1
Metadata
- Authors
- Hollander, E., Novotny, S., Hanratty, M., Yaffe, R., DeCaria, C. M., Aronowitz, B. R., & Mosovich, S.
- Affiliations
- Icahn School of Medicine at Mount Sinai (US)
- Corresponding author
- Hollander, Eric
- ORCID
- Hollander, Eric
- Venue
- Neuropsychopharmacology
- Published
- 2003-01
- Volume
- 28
- Issue
- 1
- Pages
- 193-198
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2036441276
- Cited by
- 689
- References
- 60
- Citations by year
- 2026: 7 · 2025: 14 · 2024: 15 · 2023: 15 · 2022: 23 · 2021: 22 · 2020: 27 · 2019: 15 · 2018: 29 · 2017: 33 · 2016: 47 · 2015: 49 · 2014: 49 · 2013: 51 · 2012: 44
- FWCI
- 29.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Alliance for Research on Schizophrenia and Depression
- National Institutes of Health
- National Center for Research Resources (5 M01RR00071, M01RR000071)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroendocrine regulation and behavior
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Keywords
- oxytocin, repetitive behavior, autism spectrum disorder, Asperger syndrome, autistic adults, oxytocin infusion, vasopressin, social behavior, self-harm, need to know, ordering behavior
- MeSH terms
- Adult, Autistic Disorder, Blood Pressure, Body Temperature, Double-Blind Method, Female, Humans, Infusions, Intravenous, Male, Oxytocin, Psychiatric Status Rating Scales, Pulse, Treatment Outcome, Asperger Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
